access to medicines advocacy africa aids arthritis asia asthma benefit-risk bill and melinda gates foundation bill c-51 burden of illness canada canadian agency for drugs and technologies in health cancer cardiovascular disease china chiropractic services chronic disease civil society common drug review comparative effectiveness compulsory licensing cost containment counterfeit medicines dengue fever developing countries diabetes disease management disease prevalence drug approval drug pricing emerging markets europe fda formularies france generic medicines global health global health initiative health canada health insurance health outcomes health policy health promotion health service utilization health spending health stakeholders health systems health technology assessment igwg impact importation incontinence incremental innovation india information to patients innovation intellectual property internet pharmacies japan liability malaria medicaid medical liability medicare ministry of health minnesota mood disorders neglected tropical diseases obesity ontario partnerships patents patient advocacy patient safety patient-centered care patients pepfar peru pharmaceutical industry pharmacists pharmacy prescription drugs prescription medicines price controls pricing of medicines public health public-private partnerships quality of life rare diseases regulatory system reimbursement republic of korea rx&d seniors substandard medicines supply chain thailand trips tuberculosis unaids unicef united nations usa vaccines venezuela world bank world health assembly world health organization world intellectual property office world trade organization